Examkin

Soru

Zorluk: Çok zorSchizophrenia and Psychotic Disorders

A 24-year-old woman with a 3-year history of schizophrenia is admitted to the inpatient psychiatric unit. For the past four days, she has been entirely mute, refuses all food and fluids, and maintains rigid postures for hours. When the examiner attempts to reposition her arm, it remains exactly where placed. Her current medication is oral risperidone 4 mg daily, which her parents state she took consistently until three days ago. Her vital signs are within normal limits. Arrange the following management steps in the most appropriate chronological sequence for this patient's episode of care, assuming sequential escalation is required due to refractory symptoms before eventual resolution.

  1. 1Discontinue the patient's current risperidone therapy
  2. 2Administer a test dose of intravenous lorazepam
  3. 3Initiate scheduled, high-dose lorazepam therapy
  4. 4Administer a course of electroconvulsive therapy (ECT)
  5. 5Initiate a trial of an atypical antipsychotic with low D2 receptor affinity

Cevap

The correct sequence is to first discontinue risperidone, then administer an IV lorazepam test dose, followed by scheduled high-dose lorazepam, then proceed to ECT for refractory symptoms, and finally restart a low-D2 affinity antipsychotic once catatonia has resolved.
The correct algorithm for managing catatonia begins with the immediate cessation of dopamine antagonists to prevent worsening or NMS. Once stopped, an IV lorazepam challenge confirms the diagnosis and provides temporary relief. This is followed by scheduled, high-dose benzodiazepine therapy for definitive treatment. If the patient does not respond to scheduled benzodiazepines, ECT is the indicated treatment for refractory catatonia. Finally, only after the catatonia has completely resolved, an atypical antipsychotic with low D2 receptor affinity (such as quetiapine or clozapine) should be cautiously initiated to manage the underlying schizophrenia.

Adım Adım Çözüm

1
Recognize the clinical presentation
The patient exhibits mutism, negativism (refusal to eat/drink), and waxy flexibility (arm remains where placed).
These findings are classic for catatonia, a neuropsychiatric syndrome that can occur in the context of schizophrenia or mood disorders.
2
Determine the immediate first step in management
Discontinue the offending agent, risperidone.
Continuing dopamine antagonists during acute catatonia can worsen the condition and increase the risk of progression to life-threatening neuroleptic malignant syndrome (NMS).
3
Select the initial diagnostic and therapeutic intervention
Perform a lorazepam challenge test.
Intravenous lorazepam rapidly confirms the diagnosis if the patient's catatonic signs temporarily improve.
4
Identify the definitive first-line pharmacological treatment
Start scheduled, high-dose lorazepam.
Because the challenge test only provides transient relief, a scheduled regimen is needed to achieve sustained remission of catatonic symptoms.
5
Establish the next step for treatment-refractory symptoms
Proceed to electroconvulsive therapy (ECT).
When standard pharmacological escalation fails, or if the patient develops autonomic instability, ECT is the most effective and definitive treatment for catatonia.
6
Plan for post-episode maintenance therapy
Restart an antipsychotic with a low D2 receptor affinity profile (e.g., quetiapine, clozapine).
Once catatonia has resolved, the underlying schizophrenia requires treatment. High-potency agents should be avoided to prevent recurrence of catatonia.

Anahtar Kavram

The stepwise management of catatonia in schizophrenia involves discontinuing antipsychotics, initiating a lorazepam challenge followed by scheduled benzodiazepines, utilizing ECT for refractory cases, and cautiously restarting low-potency antipsychotics only after full resolution.
Bu soruyu puanla

Konular

Schizophrenia and Psychotic Disorders

Bu konudan daha fazla soru